Press releases

Unique approach delivers phenomenal first year success for Deloitte’s national charity partnerships

13 August 2014

  • Charities highlight pro bono projects, worth £350k, as key success factors
  • Deloitte raises over £640k through fundraising, in addition to pro bono support
  • Employees benefit from improved awareness of the issues the charities address

A year after partnering with health charities, Alzheimer’s Society, Mind, and Prostate Cancer UK, Deloitte is reflecting on the success of the programme to date and planning to continue to drive impact over the next two years.

David Barnes, managing partner for public policy at Deloitte said: “The three charities we are currently supporting were selected by Deloitte employees, based on the impact we could have over the course of our three year partnership. To date we have raised over £640k and provided pro bono support to the value of £350k for the charities. Importantly, awareness of the issues they each address has also significantly increased across the firm.

“Through our pro bono work, Deloitte’s people have already helped the charities to tackle some key organisational challenges. This will continue throughout the two years ahead. For many employees there is a personal connection to one or more of the charities and the incredible efforts that are made to raise money is reflective of the strong connection our people feel to the causes.”  

The three year partnership began in June 2013 and, in the first 12 months, saw some impressive achievements. Fundraising carried out by the firm’s employees has:

  • Helped Alzheimer’s Society to deliver vital research projects for dementia care, cure and prevention, alongside facilitating its review of the National Dementia Strategy for England.
  • Supported the recruitment of an additional Infoline advisor for Mind, enabling the charity to take an extra 8,000 calls a year from people in urgent need of advice and support.
  • Enabled Prostate Cancer UK to deliver its Search and Rescue programme, helping the charity to identify 300,000 men in at risk groups.

Deloitte has further ambitious fundraising targets for the year ahead. These include a target of £200,000 it is aiming to raise via the 280 employees taking part in the Royal Parks Foundation half marathon and “Ultra” events, in the firm’s first year as corporate sponsor.

Beyond fundraising, the pro bono projects delivered by Deloitte staff have been highlighted as one of the most valuable aspects of the programme to date. The charities recognise Deloitte’s ability to offer the time and support of dedicated relationship teams, as being a unique contribution from a corporate partner that stands the relationship apart from other corporate affiliations.

For Alzheimer’s Society, Deloitte has provided expertise and guidance during the charity’s review of the National Dementia Strategy for England (NDSE). The NDSE, formed in 2009, provided a five year strategy to improve care and support for people with dementia and their families.

Deloitte is assisting with one of Mind’s broader strategic goals, helping people who are likely to develop mental health problems to stay well. Primarily, Deloitte has helped the charity develop an app for smartphones to provide support to the increasing number of people that seek mental health support online.

For Prostate Cancer UK the pro bono highlight has been access to Deloitte employees’ expertise. Deloitte’s people have been able to review the charity’s financial processes and reduce its costs. The power of the geo-spatial analytics that the firm has been able to provide, helping to map at-risk men in the UK, has also had a significant impact.

In addition, the three charities have benefited from Deloitte’s volunteering efforts, with three and a half hours a month available to every Deloitte employee to dedicate to volunteering. Over the last year, more than 3,100 Deloitte employees have been involved in volunteering activity, 90% of which has been skills-based.


End

Notes to Editors

Jon Bodenham, Director of Fundraising at Alzheimer’s Society , said: “We are delighted by Deloitte’s fundraising efforts in their first year, coupled with the superb engagement of their staff. The funds raised will make a real difference to the lives of people with dementia and their carers by funding research into dementia care, cure and prevention. Deloitte’s pro bono work has facilitated Alzheimer’s Society’s review of the government’s NDSE and illustrates that a charity partnership can go beyond fundraising alone. One in three people over the age of 65 will develop the condition. Partnerships like this one enable Alzheimer’s Society to carry out vital work to improve the lives of people affected by dementia.”

Paul Farmer, Mind’s CEO, said: “Since the launch of our partnership with Deloitte we’ve been overwhelmed by the support and dedication to challenging the stigma surrounding mental health from staff, and their fantastic fundraising achievements over the first 12 months. We’re already busy planning years two and three of the partnership, and we’re really excited about what lies ahead.”

Owen Sharp, Chief Executive at Prostate Cancer UK, said: “Our thanks go to everyone at Deloitte who has helped raise much needed funds and awareness, provided pro-bono support, and volunteered at events. As a result, the Search and Rescue Programme is well underway and we are already reaching out to men at highest risk of the disease with vital information and support. Prostate cancer is a disease which kills one man every hour, and is set to become the most common cancer of all by 2030. There really is no better time to have Deloitte on our side and we look forward to the next year working together in the fight against prostate cancer.”

About Deloitte
In this press release references to Deloitte are references to Deloitte LLP, which is among the country's leading professional services firms.

Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu Limited (“DTTL”), a UK private company limited by guarantee, whose member firms are legally separate and independent entities. Please see www.deloitte.co.uk/about for a detailed description of the legal structure of DTTL and its member firms.

The information contained in this press release is correct at the time of going to press.

Member of Deloitte Touche Tohmatsu Limited.

Did you find this useful?

Related topics